{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:49:47Z","timestamp":1792482587979,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jash.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T23:50:44Z","timestamp":1470354644000},"page":"819-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension"],"prefix":"10.1016","volume":"10","author":[{"given":"Horacio","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Norcliffe-Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-842X","authenticated-orcid":false,"given":"L. Arthur","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Rowse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jash.2016.07.009_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.jash.2016.07.009_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410260410","article-title":"Patterns of plasma levels of catechols in neurogenic orthostatic hypotension","volume":"26","author":"Goldstein","year":"1989","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.jash.2016.07.009_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","article-title":"The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism","volume":"17","author":"Ha","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.jash.2016.07.009_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","article-title":"Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management","volume":"260","author":"Metzler","year":"2013","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jash.2016.07.009_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"issue":"4","key":"10.1016\/j.jash.2016.07.009_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2004-817719","article-title":"Autonomic failure in neurodegenerative disorders","volume":"23","author":"Kaufmann","year":"2003","journal-title":"Semin Neurol"},{"issue":"5","key":"10.1016\/j.jash.2016.07.009_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","article-title":"Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?","volume":"30","author":"Palma","year":"2015","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jash.2016.07.009_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jash.2016.07.009_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10286-004-0221-z","article-title":"Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure","volume":"14","author":"Goldstein","year":"2004","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.jash.2016.07.009_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jash.2016.07.009_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jash.2016.07.009_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (NOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jash.2016.07.009_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10286-014-0229-y","article-title":"Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?","volume":"24","author":"Norcliffe-Kaufmann","year":"2014","journal-title":"Clin Auton Res"},{"issue":"9205","key":"10.1016\/j.jash.2016.07.009_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jash.2016.07.009_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","article-title":"Multiple system atrophy: using clinical pharmacology to reveal pathophysiology","volume":"25","author":"Jordan","year":"2015","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jash.2016.07.009_bib16","first-page":"S428","article-title":"A multicenter, open-label study to assess the long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension (NOH 304)","volume":"27","author":"Shill","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.jash.2016.07.009_bib17","first-page":"S424","article-title":"Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)","volume":"27","author":"Isaacson","year":"2012","journal-title":"Mov Disord"},{"issue":"21","key":"10.1016\/j.jash.2016.07.009_bib18","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/CIRCULATIONAHA.111.037036","article-title":"Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people","volume":"124","author":"White","year":"2011","journal-title":"Circulation"},{"issue":"7242","key":"10.1016\/j.jash.2016.07.009_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/bmj.320.7242.1128","article-title":"Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society","volume":"320","author":"O'Brien","year":"2000","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.jash.2016.07.009_bib20","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/mds.22767","article-title":"Loss of nocturnal blood pressure fall in various extrapyramidal syndromes","volume":"24","author":"Schmidt","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jash.2016.07.009_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/HYPERTENSIONAHA.112.195594","article-title":"\u201cThe nighttime might be the right time\u201d for cardiovascular event prediction","volume":"60","author":"White","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jash.2016.07.009_bib22","first-page":"43","article-title":"Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy","volume":"3","author":"White","year":"1998","journal-title":"Blood Press Monit"},{"issue":"5","key":"10.1016\/j.jash.2016.07.009_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","article-title":"Renal impairment of pure autonomic failure","volume":"54","author":"Garland","year":"2009","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.jash.2016.07.009_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1586\/14779072.2015.1095090","article-title":"Orthostatic hypotension: managing a difficult problem","volume":"13","author":"Jones","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.jash.2016.07.009_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","article-title":"Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone","volume":"232","author":"Ten Harkel","year":"1992","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.jash.2016.07.009_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajh\/hpt175","article-title":"Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile?","volume":"27","author":"de la Sierra","year":"2014","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.jash.2016.07.009_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/HYPERTENSIONAHA.108.124008","article-title":"Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients","volume":"53","author":"de la Sierra","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jash.2016.07.009_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e328356c52f","article-title":"Management approaches to hypertension in autonomic failure","volume":"21","author":"Arnold","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116304508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116304508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T08:21:48Z","timestamp":1536481308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171116304508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1933171116304508"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2016.07.009","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}